Author/Authors :
Hideaki Sugiyama، نويسنده , , Thomas S. McCormick، نويسنده , , Kevin D. Cooper، نويسنده , , Neil J. Korman، نويسنده ,
Abstract :
Alefacept is the first biologic agent approved by the US Food and Drug Administration for the treatment of psoriasis. To date, more than 1000 patients with moderate to severe psoriasis have been enrolled in phase III clinical trials of alefacept. More tha
